V-101: Phase II data

The double-blind, U.S. Phase II Study V-101-ROSE-202 trial in 183 patients with moderate to

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE